Ardent Health, Inc. (ARDT) · Insider trading
What Ardent Health's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$186,400
2 insiders, 2 trades
Sold, 12 months
$0
0 insiders
Net, 12 months
+$186,400
bought less sold
Latest filing
2026-09-29
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Webb Robert ThomasDirector | $339,600 | – | 2 | 2024-11-08 | 30,275 |
| DeMichiei RobertDirector | $98,300 | – | 1 | 2026-06-05 | 35,564 |
| Lumsdaine AlfredChief Financial Officer | $88,100 | – | 1 | 2026-06-05 | 329,183 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Lumsdaine AlfredChief Financial Officer | Buy | 10,000 | 8.81 | $88,100 | 329,183 | Form 4 |
| 2026-06-05 | DeMichiei RobertDirector | Buy | 11,260 | 8.73 | $98,300 | 35,564 | Form 4 |
| 2024-11-08 | Webb Robert ThomasDirector | Buy | 10,000 | 17.47 | $174,700 | 30,275 | Form 4 |
| 2024-11-08 | Webb Robert ThomasDirector | Buy | 10,000 | 16.49 | $164,900 | 40,275 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
44 × grant or award22 × shares withheld for tax
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-25 | Byers David RaynorSVP & Chief Accounting Officer | Shares withheld for tax F | −524 | 10.54 | 129,921 | Form 4 |
| 2026-09-25 | Petrovich Stephen C.EVP, GC and Secretary | Shares withheld for tax F | −788 | 10.54 | 773,919 | Form 4 |
| 2026-09-25 | Lumsdaine AlfredChief Financial Officer | Shares withheld for tax F | −3,389 | 10.54 | 325,794 | Form 4 |
| 2026-07-01 | Caspers DaveDirector, CEO and President | Grant or award A | +103,653 | – | 174,930 | Form 4 |
| 2026-04-01 | Bonick MartinDirector, President and CEO | Shares withheld for tax F | −10,952 | 8.67 | 1,303,322 | Form 4 |
| 2026-04-01 | Bonick MartinDirector, President and CEO | Grant or award A | +134,615 | – | 1,437,937 | Form 4 |
| 2026-04-01 | Lumsdaine AlfredChief Financial Officer | Shares withheld for tax F | −4,381 | 8.67 | 265,337 | Form 4 |
| 2026-04-01 | Lumsdaine AlfredChief Financial Officer | Grant or award A | +53,846 | – | 319,183 | Form 4 |
| 2026-04-01 | Byers David RaynorSVP & Chief Accounting Officer | Shares withheld for tax F | −924 | 8.67 | 118,907 | Form 4 |
| 2026-04-01 | Byers David RaynorSVP & Chief Accounting Officer | Grant or award A | +11,538 | – | 130,445 | Form 4 |
| 2026-04-01 | Petrovich Stephen C.EVP, GC and Secretary | Shares withheld for tax F | −1,808 | 8.67 | 749,803 | Form 4 |
| 2026-04-01 | Petrovich Stephen C.EVP, GC and Secretary | Grant or award A | +24,904 | – | 774,707 | Form 4 |
| 2026-04-01 | Caspers DaveChief Operating Officer | Shares withheld for tax F | −2,684 | 8.67 | 35,604 | Form 4 |
| 2026-04-01 | Caspers DaveChief Operating Officer | Grant or award A | +35,673 | – | 71,277 | Form 4 |
| 2026-04-01 | Bynoe Peter C BDirector | Grant or award A | +14,231 | – | 115,367 | Form 4 |
| 2026-04-01 | Campion SuzanneDirector | Grant or award A | +14,231 | – | 58,215 | Form 4 |
| 2026-04-01 | Goodyear William MDirector | Grant or award A | +14,231 | – | 115,367 | Form 4 |
| 2026-04-01 | DeMichiei RobertDirector | Grant or award A | +14,231 | – | 24,304 | Form 4 |
| 2026-04-01 | Robinson EdmondoDirector | Grant or award A | +14,231 | – | 58,215 | Form 4 |
| 2026-04-01 | Webb Robert ThomasDirector | Grant or award A | +14,231 | – | 78,215 | Form 4 |
| 2026-04-01 | Sen RahulDirector | Grant or award A | +14,231 | – | 38,709 | Form 4 |
| 2026-04-01 | Sotir Mark RDirector, Other | Grant or award A | +14,231 | – | 38,709 | Form 4 |
| 2026-04-01 | Havdala EllenDirector | Grant or award A | +14,231 | – | 115,367 | Form 4 |
| 2026-04-01 | Bulgarelli Peter J.Director | Grant or award A | +14,231 | – | 14,231 | Form 4 |
| 2026-03-31 | Bonick MartinDirector, President and CEO | Shares withheld for tax F | −8,026 | 8.56 | 1,314,274 | Form 4 |
| 2026-03-31 | Lumsdaine AlfredChief Financial Officer | Shares withheld for tax F | −2,510 | 8.56 | 269,718 | Form 4 |
| 2026-03-31 | Byers David RaynorSVP & Chief Accounting Officer | Shares withheld for tax F | −819 | 8.56 | 119,831 | Form 4 |
| 2026-03-31 | Petrovich Stephen C.EVP, GC and Secretary | Shares withheld for tax F | −1,425 | 8.56 | 751,611 | Form 4 |
| 2026-03-11 | Byers David RaynorSVP & Chief Accounting Officer | Grant or award A | +8,859 | – | 120,650 | Form 4 |
| 2026-03-11 | Bonick MartinDirector, President and CEO | Grant or award A | +195,316 | – | 1,322,300 | Form 4 |
| 2026-03-11 | Chernin EthanPresident of Health Services | Grant or award A | +32,408 | – | 68,396 | Form 4 |
| 2026-03-11 | Lumsdaine AlfredChief Financial Officer | Grant or award A | +61,081 | – | 272,228 | Form 4 |
| 2026-03-11 | Petrovich Stephen C.EVP, GC and Secretary | Grant or award A | +34,733 | – | 753,036 | Form 4 |
| 2025-09-25 | Byers David RaynorSVP & Chief Accounting Officer | Shares withheld for tax F | −524 | 13.19 | 111,791 | Form 4 |
| 2025-09-25 | Petrovich Stephen C.EVP, GC and Asst. Secretary | Shares withheld for tax F | −788 | 13.19 | 718,303 | Form 4 |
| 2025-09-25 | Lumsdaine AlfredChief Financial Officer | Shares withheld for tax F | −3,389 | 13.19 | 211,147 | Form 4 |
| 2025-04-02 | DeMichiei RobertDirector | Grant or award A | +10,073 | – | 10,073 | Form 4 |
| 2025-04-01 | Bonick MartinDirector, President and CEO | Grant or award A | +134,927 | – | 1,126,984 | Form 4 |
| 2025-04-01 | Lumsdaine AlfredChief Financial Officer | Grant or award A | +53,971 | – | 214,536 | Form 4 |
| 2025-04-01 | Petrovich Stephen C.EVP, GC and Asst. Secretary | Grant or award A | +22,263 | – | 719,091 | Form 4 |
| 2025-04-01 | Schultz DavidPresident Hospital Operations | Grant or award A | +26,985 | – | 64,172 | Form 4 |
| 2025-04-01 | Chernin EthanPresident of Health Services | Grant or award A | +20,914 | – | 35,988 | Form 4 |
| 2025-04-01 | Byers David RaynorSVP & Chief Accounting Officer | Grant or award A | +11,565 | – | 112,315 | Form 4 |
| 2025-04-01 | Caspers DaveChief Operating Officer | Grant or award A | +7,711 | – | 7,711 | Form 4 |
| 2025-04-01 | Caspers DaveChief Operating Officer | Shares withheld for tax F | −2,480 | 12.97 | 5,231 | Form 4 |
| 2025-04-01 | Caspers DaveChief Operating Officer | Grant or award A | +33,057 | – | 38,288 | Form 4 |
| 2025-03-31 | Bonick MartinDirector, President and CEO | Shares withheld for tax F | −12,970 | 13.75 | 992,057 | Form 4 |
| 2025-03-31 | Lumsdaine AlfredChief Financial Officer | Shares withheld for tax F | −2,510 | 13.75 | 160,565 | Form 4 |
| 2025-03-31 | Petrovich Stephen C.EVP, GC and Asst. Secretary | Shares withheld for tax F | −1,428 | 13.75 | 696,828 | Form 4 |
| 2025-03-31 | Schultz DavidPresident Hospital Operations | Shares withheld for tax F | −1,825 | 13.75 | 37,187 | Form 4 |
| 2025-03-31 | Chernin EthanPresident of Health Services | Shares withheld for tax F | −1,332 | 13.75 | 15,074 | Form 4 |
| 2025-03-31 | Byers David RaynorSVP & Chief Accounting Officer | Shares withheld for tax F | −676 | 13.75 | 100,750 | Form 4 |
| 2025-03-21 | Webb Robert ThomasDirector | Grant or award A | +12,916 | – | 63,984 | Form 4 |
| 2025-03-21 | Robinson EdmondoDirector | Grant or award A | +12,916 | – | 43,984 | Form 4 |
| 2025-03-21 | Sotir Mark RDirector, Other | Grant or award A | +12,916 | – | 24,478 | Form 4 |
| 2025-03-21 | Sen RahulDirector | Grant or award A | +12,916 | – | 24,478 | Form 4 |
| 2025-03-21 | Havdala EllenDirector | Grant or award A | +12,916 | – | 101,136 | Form 4 |
| 2025-03-21 | Goodyear William MDirector | Grant or award A | +12,916 | – | 101,136 | Form 4 |
| 2025-03-21 | Bynoe Peter C BDirector | Grant or award A | +12,916 | – | 101,136 | Form 4 |
| 2025-03-21 | Campion SuzanneDirector | Grant or award A | +12,916 | – | 43,984 | Form 4 |
| 2024-12-12 | Goodyear William MDirector | Grant or award A | +10,793 | – | 88,220 | Form 4 |
| 2024-12-12 | Campion SuzanneDirector | Grant or award A | +10,793 | – | 31,068 | Form 4 |
| 2024-12-12 | Bynoe Peter C BDirector | Grant or award A | +10,793 | – | 88,220 | Form 4 |
| 2024-12-12 | Havdala EllenDirector | Grant or award A | +10,793 | – | 88,220 | Form 4 |
| 2024-12-12 | Robinson EdmondoDirector | Grant or award A | +10,793 | – | 31,068 | Form 4 |
| 2024-12-12 | Webb Robert ThomasDirector | Grant or award A | +10,793 | – | 51,068 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.